Versant Ventures Vi Gp-gp, Llc - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Ventures Vi Gp-gp, Llc made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 34,270 shares made by Lloyd Mitchell Segal , a net sale of 10,973 shares made by Steve Forte , and a net sale of 7,821 shares made by Michael Zinda .

In summary, during the past 3 months, insiders sold 37,270 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 37,270 shares. During the past 18 months, 58,960 shares of Repare Therapeutics Inc (RPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,960 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Ventures Vi Gp-gp, Llc made no insider transaction in Passage Bio Inc (PASG). Other recent insider transactions involving Passage Bio Inc (PASG) include a net sale of 1,384,000 shares made by Orbimed Advisors Llc , a net purchase of 829,998 shares made by Lynx1 Capital Management Lp , and a net sale of 4,653 shares made by Kathleen Borthwick .

In summary, during the past 3 months, insiders sold 384,626 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 384,626 shares. During the past 18 months, 1,390,291 shares of Passage Bio Inc (PASG) were sold and 829,998 shares were bought by its insiders, resulting in a net sale of 560,293 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Ventures Vi Gp-gp, Llc made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 268,578 shares made by Catriona Yale , a net sale of 223,518 shares made by Jonathan Young , and a net sale of 499,800 shares made by Andrew Cheng .

In summary, during the past 3 months, insiders sold 164,224 shares of Akero Therapeutics Inc (AKRO) in total and bought 200,000 shares, with a net purchase of 35,776 shares. During the past 18 months, 1,407,872 shares of Akero Therapeutics Inc (AKRO) were sold and 500,000 shares were bought by its insiders, resulting in a net sale of 907,872 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Ventures Vi Gp-gp, Llc made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 60,615 shares of Tempest Therapeutics Inc (TPST) were sold and 3,052 shares were bought by its insiders, resulting in a net sale of 57,564 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Graphite Bio Inc (GRPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graphite Bio Inc (GRPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Graphite Bio Inc (GRPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Ventures Vi Gp-gp, Llc made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , a net sale of 4,879 shares made by Edmund Dunn , and a net purchase of 10,000 shares made by Chandra P. Leo .

In summary, during the past 3 months, insiders sold 2,062 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 10,000 shares, with a net purchase of 7,938 shares. During the past 18 months, 1,862,553 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 1,852,553 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Versant Ventures Vi Gp-gp, Llc made no insider transaction in Century Therapeutics Inc (IPSC). Other recent insider transactions involving Century Therapeutics Inc (IPSC) include a net sale of 65,275 shares made by Adrienne Farid , a net sale of 29,746 shares made by Gregory Russotti , and a net sale of 3,915 shares made by Douglas Carr .

In summary, during the past 3 months, insiders sold 39,065 shares of Century Therapeutics Inc (IPSC) in total and bought 0 shares, with a net sale of 39,065 shares. During the past 18 months, 165,435 shares of Century Therapeutics Inc (IPSC) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 160,435 shares.

Century Therapeutics Inc (IPSC)'s detailed insider trading history can be found in Insider Trading Tracker table.